JP2007512381A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512381A5 JP2007512381A5 JP2006541869A JP2006541869A JP2007512381A5 JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5 JP 2006541869 A JP2006541869 A JP 2006541869A JP 2006541869 A JP2006541869 A JP 2006541869A JP 2007512381 A5 JP2007512381 A5 JP 2007512381A5
- Authority
- JP
- Japan
- Prior art keywords
- arthritis
- medicament
- combination
- rheumatoid arthritis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0327840.5A GB0327840D0 (en) | 2003-12-01 | 2003-12-01 | Organic compounds |
| PCT/EP2004/013587 WO2005053661A2 (en) | 2003-12-01 | 2004-11-30 | Pharmaceutical combinations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007512381A JP2007512381A (ja) | 2007-05-17 |
| JP2007512381A5 true JP2007512381A5 (cg-RX-API-DMAC10.html) | 2008-01-24 |
Family
ID=29798110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006541869A Pending JP2007512381A (ja) | 2003-12-01 | 2004-11-30 | 医薬的組み合わせ |
Country Status (11)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1478648B1 (en) | 2002-02-01 | 2014-04-30 | ARIAD Pharmaceuticals, Inc. | Phosphorus-containing compounds and uses thereof |
| WO2006053754A1 (en) * | 2004-11-19 | 2006-05-26 | Novartis Ag | COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE |
| AU2006315512B2 (en) * | 2005-11-14 | 2012-11-01 | Ariad Pharmaceuticals, Inc. | Administration of an mTOR inhibitor to treat patients with cancer |
| EP1880723A1 (en) * | 2006-07-14 | 2008-01-23 | Novartis AG | Combination of mTOR inhibitor and antifolate compound |
| JP2009523149A (ja) * | 2006-01-12 | 2009-06-18 | ノバルティス アクチエンゲゼルシャフト | ｍＴＯＲ阻害剤および抗葉酸化合物の組み合わせ |
| KR20140016439A (ko) * | 2006-02-02 | 2014-02-07 | 노파르티스 아게 | 결절성 경화증의 치료 |
| US20090023768A1 (en) * | 2006-02-24 | 2009-01-22 | Novartis Ag | Rapamycin derivatives for treating neuroblastoma |
| CA2669415A1 (en) | 2006-11-14 | 2008-05-22 | Ariad Pharmaceuticals, Inc. | Solid dosage form comprising ap23573 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| US5258389A (en) * | 1992-11-09 | 1993-11-02 | Merck & Co., Inc. | O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives |
| DE69624921T2 (de) * | 1995-06-09 | 2003-09-11 | Novartis Ag, Basel | Rapamycinderivate |
| GB0123025D0 (en) * | 2001-09-25 | 2001-11-14 | Eirx Therapeutics Ltd | Apoptosis |
| JP2005514411A (ja) * | 2002-01-10 | 2005-05-19 | ノバルティス アクチエンゲゼルシャフト | ラパマイシンおよびその誘導体を含む血管疾患の予防および処置用薬剤送達システム |
| EP1478648B1 (en) * | 2002-02-01 | 2014-04-30 | ARIAD Pharmaceuticals, Inc. | Phosphorus-containing compounds and uses thereof |
| WO2003106622A2 (en) * | 2002-05-30 | 2003-12-24 | The Children's Hospital Of Philadelphia | Methods for treatment of acute lymphocytic leukemia |
| TW200902047A (en) * | 2003-02-14 | 2009-01-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
-
2003
- 2003-12-01 GB GBGB0327840.5A patent/GB0327840D0/en not_active Ceased
-
2004
- 2004-11-30 KR KR1020067010547A patent/KR20060122877A/ko not_active Withdrawn
- 2004-11-30 US US10/581,069 patent/US20070117833A1/en not_active Abandoned
- 2004-11-30 CN CNA2004800355130A patent/CN1886157A/zh active Pending
- 2004-11-30 JP JP2006541869A patent/JP2007512381A/ja active Pending
- 2004-11-30 RU RU2006123312/15A patent/RU2006123312A/ru not_active Application Discontinuation
- 2004-11-30 BR BRPI0417146-2A patent/BRPI0417146A/pt not_active IP Right Cessation
- 2004-11-30 AU AU2004294282A patent/AU2004294282B2/en not_active Expired - Fee Related
- 2004-11-30 WO PCT/EP2004/013587 patent/WO2005053661A2/en not_active Ceased
- 2004-11-30 CA CA002546738A patent/CA2546738A1/en not_active Abandoned
- 2004-11-30 EP EP04803369A patent/EP1819361A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10561618B2 (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders | |
| JP5796959B2 (ja) | 関節炎における痛みの治療のためのタペンタドール | |
| WO2016062283A1 (zh) | 抗发炎用药物在制备抑制癌症的医药组合物中的应用 | |
| JP2013521304A5 (cg-RX-API-DMAC10.html) | ||
| JP2008539250A (ja) | アテローム性動脈硬化症を処置するための方法 | |
| HRP20251043T1 (hr) | Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća | |
| JP2020519576A5 (cg-RX-API-DMAC10.html) | ||
| WO2014199294A1 (en) | Pharmaceutical combinations of a pi3k inhibitor and a microtubule destabilizing agent | |
| JP2016505050A5 (cg-RX-API-DMAC10.html) | ||
| RU2007119067A (ru) | Средство для лечения синдрома раздраженного кишечника с преобладанием диареи | |
| US10576076B2 (en) | Pharmaceutical combination of everolimus with dactolisib | |
| JP2022549137A (ja) | イブジラスト経口製剤およびその使用方法 | |
| Kris et al. | Control of chemotherapy-induced diarrhea with the synthetic enkephalin BW942C: a randomized trial with placebo in patients receiving cisplatin. | |
| Kumar et al. | Cilostazol: a new drug in the treatment intermittent claudication | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| WO2006086500A2 (en) | Compositions and methods for treating vascular, autoimmune and inflammatory diseases | |
| JP2010508253A5 (cg-RX-API-DMAC10.html) | ||
| EP3789020A1 (en) | Fixed dose composition of paracetamol: amitriptyline and method for the treatment of mixed cancer pain | |
| JP2008527034A5 (cg-RX-API-DMAC10.html) | ||
| ZA202206042B (en) | Treating behavioral and psychological symptoms in dementia patients | |
| JP2006076945A (ja) | 線維筋痛症候群の治療剤 | |
| WO2017017511A1 (en) | Modified release formulation for treating premature ejaculation | |
| JP2004244347A (ja) | イトラコナゾール併用剤 | |
| HK1207285B (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders | |
| BRPI0503488A (pt) | agente de tratamento para sìndrome de intestino irritável com diarréia predominante |